Tranexamic acid (Transamin) blocks the lysine binding site of plasmin and the plasminogen fragment developed from elastase.
These protocols are for reference only. InvivoChem does not independently validate these methods.
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Effect of Tranexamic Acid on Intraoperative Blood Loss in Patients Undergoing Aquablation
CTID: NCT06710327
Phase: Phase 4 Status: Not yet recruiting
Date: 2024-11-29
Effect of Tranexamic Acid and Calcium Dobesilate for Bleeding of Endometrial Origin
CTID: NCT06707051
Phase: Phase 2/Phase 3 Status: Completed
Date: 2024-11-27
Tranexamic Acid Use on Pain, Mobility and Bleeding Following Total Hip and Total Knee Arthroplasty
CTID: NCT06208267
Phase: N/A Status: Not yet recruiting
Date: 2024-11-26
Topical Tranexamic Acid Use on Granulating Wounds Following Mohs Micrographic Surgery
CTID: NCT04541303
PhaseEarly Phase 1 Status: Completed
Date: 2024-11-21
Use of Tranexamic Acid in Reduction of Post-Op Complications in Mohs Micrographic Surgery
CTID: NCT04630886
PhaseEarly Phase 1 Status: Terminated
Date: 2024-11-19
View More
Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children
CTID: NCT06070350
Phase: Phase 3 Status: Recruiting
Date: 2024-11-13
Prevent Postpartum Hemorrhage in Women with Von Willebrand Disease: the VWD-WOMAN Trial
CTID: NCT04344860
Phase: Phase 3 Status: Completed
Date: 2024-11-13
The Effect of Local and Systemic Tranexamic Acid on Edema and Ecchymosis in Orbital Surgery
CTID: NCT06450392
Phase: Phase 4 Status: Recruiting
Date: 2024-11-12
Tranexamic Acid in Patients for Caesarian Delivery.
CTID: NCT05759156
Phase: N/A Status: Completed
Date: 2024-11-07
Tranexamic Acid for the Prevention of Postpartum Hemorrhage in Pregnant Women with Placenta Previa
CTID: NCT05811676
Phase: Phase 3 Status: Recruiting
Date: 2024-10-31
Effect of TXA on Reducing Bruising After Filler Injection
CTID: NCT06665594
Phase: Phase 2 Status: Not yet recruiting
Date: 2024-10-30
Efficacy and Safety of Retrograde Intraarticular Injection, Topical Soaking of Tranexamic Acid (TXA), or Placebo in Femoral Neck Fractured Patients Undergoing Cementless Bipolar Hemiarthroplasty
CTID: NCT06289478
Phase: N/A Status: Recruiting
Date: 2024-10-30
Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery
CTID: NCT06657924
Phase: Phase 2 Status: Not yet recruiting
Date: 2024-10-26
A Pilot Study Comparing Anti-Inflammatory Effects Of TXA Versus EACA In Pediatric Congenital Heart Surgery
CTID: NCT02656472
Phase: Phase 4 Status: Completed
Date: 2024-10-24
Prophylactic Tranexamic Acid To Reduce Blood Loss During Caesarean Delivery.
CTID: NCT06604325
Phase: N/A Status: Recruiting
Date: 2024-10-24
Comparison of Chitosan, Ankaferd and Tranexamic Acid in Dental Extraction in Liver Pre-Transplant Children
CTID: NCT06457360
PhaseEarly Phase 1 Status: Completed
Date: 2024-10-18
EFFECTS of TRANEXAMIC ACID in TUMESCENT SOLUTION for LIPOSUCTION PROCEDURES
CTID: NCT06648265
Phase: Phase 4 Status: Completed
Date: 2024-10-18
Window of Opportunity Study of Topical Tranexamic Acid for Cutaneous Squamous Cell Carcinoma
CTID: NCT06644079
Phase: Phase 2 Status: Not yet recruiting
Date: 2024-10-16
The Effect of Local Application of Tranexamic Acid Versus Placebo on Postoperative Complications in Plastic Surgery.
CTID: NCT06270407
Phase: Phase 4 Status: Recruiting
Date: 2024-10-16
Tranexamic Acid for Reduction of Transfusion in Abdominal Surgery
CTID: NCT06414031
Phase: Phase 3 Status: Recruiting
Date: 2024-10-15
Effect of TXA on Blood Loss in Reverse Total Shoulder Arthroplasty
CTID: NCT06638749
Phase: Phase 3 Status: Withdrawn
Date: 2024-10-15
Tranexamic Acid as an Intervention in Placenta Previa
CTID: NCT05688111
Phase: N/A Status: Completed
Date: 2024-10-15
Burn Study- Tranexamic Acid Versus Thrombin in Split Thickness Skin Graft
CTID: NCT06379724
Phase: Phase 4 Status: Recruiting
Date: 2024-10-08
Extended Oral Tranexamic Acid After Total Knee Arthroplasty
CTID: NCT06618820
Phase: Phase 3 Status: Enrolling by invitation
Date: 2024-10-01
Effect of Tranexamic Acid (TXA) on Reduction of Postoperative Blood Transfusion
CTID: NCT03063892
Phase: Phase 4 Status: Recruiting
Date: 2024-09-19
Evaluation of Tranexamic Acid in Myelodysplastic Syndromes and Acute Myeloid Leukemia
CTID: NCT06599762
Phase: N/A Status: Not yet recruiting
Date: 2024-09-19
Use of Tranexamic Acid After Vaginal Delivery With Episiotomy a RCT Placebo Control Trail
CTID: NCT05448456
Phase: Phase 4 Status: Completed
Date: 2024-09-19
Von Willebrand Factor in Pregnancy (VIP) Study
CTID: NCT04146376
Phase: Status: Recruiting
Date: 2024-09-19
Tranexamic Acid Versus Dexmedetomidine for Improving Surgical Field Quality During Spine Surgeries
CTID: NCT06587620
Phase: N/A Status: Completed
Date: 2024-09-19
Tranexamic Acid in Reducing Blood Loss in Patients with Pelvic Tumors Undergoing Hemipelvectomy Surgery
CTID: NCT03128866
PhaseEarly Phase 1 Status: Recruiting
Date: 2024-09-19
The Use of Tranexamic Acid in the Treatment of Symptomatic Subdural Hematoma
CTID: NCT05713630
Phase: Phase 3 Status: Not yet recruiting
Date: 2024-09-19
Postpartum Hemorrhage Reduction With Oral Tranexamic Acid: a Clinical Trial
CTID: NCT06025916
Phase: Phase 4 Status: Recruiting
Date: 2024-09-19
Comparing Intramyometrial Tranexamic Acid and Oxytocin for Blood Loss in Cesarean Section
CTID: NCT06010368
Phase: Phase 3 Status: Not yet recruiting
Date: 2024-09-05
Effect on Post-operative Pain of Tranexamic Acid Injection During Shoulder Surgery
CTID: NCT05302986
Phase: Phase 3 Status: Recruiting
Date: 2024-09-03
Prophylactic Endobronchial Tranexamic Acid to Reduce Bleeding in Transbronchial Cryobiopsy
CTID: NCT06266546
Phase: Phase 3 Status: Active, not recruiting
Date: 2024-08-21
A Randomized Control Trial Assessing the Effect of Topical Tranexamic Acid on Risk of Hematoma in Breast Surgery
CTID: NCT05441592
Phase: Phase 4 Status: Recruiting
Date: 2024-08-20
Tranexamic Acid During Colonic Endoscopic Resection Procedures
CTID: NCT05345613
Phase: Phase 4 Status: Recruiting
Date: 2024-08-07
Tranexamic Acid To Reduce Bleeding in Patients Treated With New Oral Anticoagulants Undergoing Dental Extraction
CTID: NCT03413891
Phase: Phase 4 Status: Terminated
Date: 2024-08-01
Effect of TXA Oral Sol 5% in Patients Treated With DOACs or VKA and Undergoing a Single or Multiple Tooth Extraction
CTID: NCT06143787
Phase: Phase 3 Status: Recruiting
Date: 2024-08-01
Early Tranexamic Acid and Modulating the Inflammatory Response in Sepsis
CTID: NCT04910464
Phase: Phase 3 Status: Recruiting
Date: 2024-07-31
California Prehospital and In Hospital Antifibrinolytic Therapy Via TXA
CTID: NCT03469947
Phase: Phase 3 Status: Completed
Date: 2024-07-30
Fractional Erbium YAG Laser vs Intradermal and Systemic Tranexamic Acid
CTID: NCT06522984
Phase: N/A Status: Recruiting
Date: 2024-07-26
Tranexamic Acid for Anaemia Trial
CTID: NCT06519422
Phase: Phase 3 Status: Not yet recruiting
Date: 2024-07-25
A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients
CTID: NCT05053867
Phase: Phase 3 Status: Recruiting
Date: 2024-07-24
Prevention of Postpartum Hemorrhage With Tranexamic Acid (Phase 2)
CTID: NCT05370820
Phase: Phase 2 Status: Recruiting
Date: 2024-07-24
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
CTID: NCT03511118
Phase: Status: Recruiting
Date: 2024-07-24
Development of Products Based on Secretom From Stem Cell Conditioned Medium for Melasma Therapy
CTID: NCT06516419
Phase: N/A Status: Recruiting
Date: 2024-07-24
Comparing Tranexamic Acid Versus Ecbolics in Preventing Hemorrhage During and After Cesarean Section
CTID: NCT06060327
Phase: N/A Status: Completed
Date: 2024-07-23
Use of Tranexamic Acid in Blepharoplasties
CTID: NCT04724772
Phase: Phase 3 Status: Withdrawn
Date: 2024-07-23
Efficacy of Topical Tranexamic Acid in Reducing Blood Loss During CS in Patients With Placenta Previa
CTID: NCT06515535
Phase: N/A Status: Not yet recruiting
Date: 2024-07-23
Different Methods of Tranexamic Acid Application in Controlling Peri Operative Bleeding in Gynecomastia Surgery
CTID: NCT06509256
PhaseEarly Phase 1 Status: Not yet recruiting
Date: 2024-07-19
ITCH Trial: Protocol for a Randomized, Double Blind Placebo-controlled Trial
CTID: NCT04742205
Phase: Phase 2/Phase 3 Status: Completed
Date: 2024-07-16
Minimize Menorrhagia in Women With Von Willebrand Disease
CTID: NCT02606045
Phase: Phase 3 Status: Terminated
Date: 2024-07-01
Effects of Oral Tranexamic Acid Following Total Knee Arthroplasty
CTID: NCT06479161
Phase: Phase 2 Status: Recruiting
Date: 2024-06-28
Evaluating Postoperative Non-Opioid Pain Management Utilizing Local Anesthetics Coupled With Modulated Coagulation
CTID: NCT04814433
Phase: Phase 4 Status: Terminated
Date: 2024-06-26
A Study to Evaluate LB1148 for Return of Gastrointestinal Function and Adhesions in Subjects Undergoing Bowel Resection
CTID: NCT02836470
Phase: Phase 2 Status: Completed
Date: 2024-06-21
Tranexamic Acid to Prevent OpeRation in Chronic Subdural Hematoma
CTID: NCT03582293
Phase: Phase 3 Status: Recruiting
Date: 2024-06-20
Efficacy of Tranexamic Acid (TXA) in Humerus ORIF
CTID: NCT05802238
Phase: Phase 2 Status: Recruiting
Date: 2024-06-14
A Study to Evaluate LB1148 for Return of Bowel Function in Subjects Undergoing Bowel Resection
CTID: NCT05470387
Phase: Phase 3 Status: Terminated
Date: 2024-06-13
TRanEXamic Acid to Decrease Heavy Menstrual Bleeding in Individuals Anticoagulated for Venous Thromboembolism Pilot Study
CTID: NCT06452342
Phase: Phase 4 Status: Not yet recruiting
Date: 2024-06-12
Role of TXA in Patients Undergoing Breast Free Flap Reconstruction
CTID: NCT06428682
Phase: Phase 4 Status: Recruiting
Date: 2024-06-05
Evaluations of the Effects of Tranexamic Acid and Chlorhexidine Gel on Alveolar Osteitis Incidence
CTID: NCT06435832
Phase: N/A Status: Active, not recruiting
Date: 2024-05-30
Intravenous Tranexamic Acid and Intramyometrial Desmopressin Effect on Blood Loss During Laparoscopic Myomectomy.
CTID: NCT05517590
Phase: N/A Status: Completed
Date: 2024-05-24
Effect of Topical Tranexamic Acid on Postoperative Drainage in Minimally Invasive Transforaminal Lumbar Interbody Fusion (MI-TLIF)
CTID: NCT06427850
Phase: N/A Status: Not yet recruiting
Date: 2024-05-24
Protest Trial: TXA vs Saline
CTID: NCT06422273
Phase: Phase 3 Status: Enrolling by invitation
Date: 2024-05-20
Tranexamic Acid in Vaginal Reconstructive Surgery
CTID: NCT06419075
Phase: Phase 4 Status: Not yet recruiting
Date: 2024-05-17
Nebulized Tranexamic Acid in Sinus Surgery
CTID: NCT04905901
Phase: Phase 3 Status: Recruiting
Date: 2024-05-17
Tranexamic Acid to Improve Same-day Discharge Rates After Holmium Laser Enucleation of the Prostate (HoLEP)
CTID: NCT05082142
Phase: Phase 4 Status: Completed
Date: 2024-05-16
A Trial of a Hospital Policy of Tranexamic Acid Use to Reduce Transfusion in Major Non-cardiac Surgery
CTID: NCT04803747
Phase: Phase 4 Status: Active, not recruiting
Date: 2024-05-16
TXA in Spinal Fusion
CTID: NCT04272606
Phase: Phase 2 Status: Active, not recruiting
Date: 2024-05-14
Evaluating the Effect of Tranexamic Acid on the Clinical Outcomes in Patients With Traumatic Brain Injury
CTID: NCT06330935
Phase: Phase 1/Phase 2 Status: Recruiting
Date: 2024-05-10
Impact of Topical Tranexamic Acid in Breast Reconstruction
CTID: NCT05807074
Phase: Phase 4 Status: Recruiting
Date: 2024-05-09
ACid Tranexamic or Terlipressin for Initial Emergency Treatment of Mild to seVere hEmoptysis: a Randomized Trial.
CTID: NCT04961528
Phase: Phase 3 Status: Recruiting
Date: 2024-05-03
The Efficacy of Tranexamic Acid in the Treatment of Lichen Planus Pigmentosus and Erythema Dyschromicum Perstans
CTID: NCT04233749
Phase: Phase 2 Status: Recruiting
Date: 2024-05-02
Indian Trial of Tranexamic Acid in Spontaneous Intracerebral Haemorrhage
CTID: NCT05836831
Phase: Phase 4 Status: Recruiting
Date: 2024-04-30
Topical TRanexamic Acid vs. Placebo on Acute Postoperative Pain Following DRF Fixation
CTID: NCT06384456
Phase: Phase 4 Status: Not yet recruiting
Date: 2024-04-26
Tranexamic Acid to Prevent Heavy Bleeding After Childbirth in Women at Higher Risk
CTID: NCT05562609
Phase: Phase 3 Status: Recruiting
Date: 2024-04-25
Tranexamic Acid and Depot-Medroxyprogesterone Acetate for Perimenopausal Irregular Uterine Bleeding
CTID: NCT04710017
Phase: N/A Status: Completed
Date: 2024-04-24
Do Patients Who Received Tranexamic Acid in Vaginal Hysterectomy Loose Les Blood, Comparing to Patients Who Did Not?
CTID: NCT05921071
Phase: N/A Status: Recruiting
Date: 2024-04-23
Tranexamic Acid to Reduce Blood Loss in Spine Trauma Surgery
CTID: NCT02314988
Phase: Phase 2/Phase 3 Status: Recruiting
Date: 2024-04-15
Rate of Tranexamic Acid Administration on Blood Pressure (RateTXA) Study.
CTID: NCT06356948
Phase: Phase 4 Status: Recruiting
Date: 2024-04-10
Tranexamic Acid in Adult Spinal Deformity Surgery
CTID: NCT03553186
Phase: Phase 3 Status: Recruiting
Date: 2024-04-08
TRANexamic Acid to Reduce Bleeding in BURN Surgery
CTID: NCT03113253
Phase: Phase 4 Status: Completed
Date: 2024-04-04
Tranexamic Acid to Reduce Contraceptive-related Bleeding Side Effects
CTID: NCT06000423
Phase: Phase 4 Status: Recruiting
Date: 2024-04-03
Tranexamic Acid to Prevent Bleeding After Endoscopic Resection of Large Colorectal Polyps: A Pilot Project
CTID: NCT04559880
Phase: Phase 4 Status: Completed
Date: 2024-04-03
Tranexamic Acid to Improve Arthroscopic Visualization in Shoulder Surgery
CTID: NCT04594408
Phase: Phase 4 Status: Completed
Date: 2024-04-02
The Effects of Tranexamic Acid on Joint Inflammation and Cartilage Health in Anterior Cruciate Ligament Injured Patients
CTID: NCT03552705
Phase: Phase 2 Status: Recruiting
Date: 2024-03-28
TXA in Anticoagulated Patients Study
CTID: NCT04560010
Phase: Phase 4 Status: Terminated
Date: 2024-03-26
Tranexamic Acid Use to Reduce Blood Transfusion in Pediatric Cancer Patients Undergoing Limb Salvage Procedure
CTID: NCT04410042
Phase: Phase 3 Status: Terminated
Date: 2024-03-15
Tranexamic Acid During Excisional Burn Surgery
CTID: NCT05507983
Phase: Phase 3 Status: Recruiting
Date: 2024-03-13
Effectiveness Of Tranexamic Acıd Application Wıth Different Doses On Bleeding, Edema And Physician Comfort In Orthognathıc Surgery Patients
CTID: NCT06301204
Phase: N/A Status: Completed
Date: 2024-03-08
Vasopressin Versus Tranexamic Acid for Control of Blood Loss Related to A
READY 2: A PHASE 3, OPEN LABEL, SINGLE ARM STUDY ON THE USE OF CUSA-081 FOR DYSFUNCTIONAL CENTRAL VENOUS ACCESS DEVICES (CVADs)
CTID: null
Phase: Phase 3 Status: Prematurely Ended
Date: 2022-02-14
Topical use of tranexamic acid for optimisation of wound healing in a novel, acute wound model
CTID: null
Phase: Phase 4 Status: Prematurely Ended
Date: 2021-08-30
The effect of tranexamic acid on seroma formation after mastectomies
CTID: null
Phase: Phase 4 Status: Prematurely Ended
Date: 2021-08-30
MULTICENTER, DOUBLE BLIND CLINICAL TRIAL TO EVALUATE THE ANTIHEMORRAGIC EFFECT OF THE TOPICAL TRANEXAMIC ACID DURING PACEMAKER IN ANTICOAGULATED PATIENTS
CTID: null
Phase: Phase 3 Status: Ongoing
Date: 2021-06-17
ACTIVE : ACid tranexamic or Terlipressin for Initial emergency treatment of mild to seVere hEmoptysis
CTID: null
Phase: Phase 3 Status: Trial now transitioned
Date: 2021-04-02
Study of the noninferiority of an oral versus intravenous administration of tranexamic acid in total hip arthroplasty
CTID: null
Phase: Phase 4 Status: Ongoing
Date: 2021-03-15
Evaluation of intra articular Tranexamic acid for reduction of total blood loss in total hip arthroplasty
CTID: null
Phase: Phase 2 Status: Trial now transitioned
Date: 2021-01-21
Intramuscular tranexamic acid for the treatment of symptomatic mild traumatic brain injury in older adults: a randomised, double-blind, placebo-controlled trial.
CTID: null
Phase: Phase 3 Status: GB - no longer in EU/EEA
Date: 2020-12-17
PEROPERATIVE TRANEXAMIC ACID IN BARIATRIC FAST TRACK SURGERY TO REDUCE
CTID: null
Phase: Phase 4 Status: Ongoing
Date: 2020-11-05
A multi-centre randomised, double-blind, placebo-controlled trial of pre-hospital treatment with tranexamic acid for severely injured
CTID: null
Phase: Phase 3 Status: Completed
Date: 2020-11-03
TRAnexamic Acid for Preventing blood loss following a cesarean delivery in women with placenta pREVIA: a multicenter randomised, double blind placebo controlled trial (TRAAPrevia)
CTID: null
Phase: Phase 3 Status: Trial now transitioned
Date: 2020-03-12
Heavy menstrual bleeding in premenopausal women treated with direct oral anticoagulants - the MEDEA study
CTID: null
Phase: Phase 4 Status: Prematurely Ended
Date: 2019-11-12
Pharmacokinetics of Tranexamic Acid after oral, intramuscular or intravenous administration: a prospective, randomised, cross-over trial in healthy volunteers.
CTID: null
Phase: Phase 2 Status: Completed
Date: 2019-08-21
Pharmacokinetics of intramuscular tranexamic acid in trauma patients: a clinical trial
CTID: null
Phase: Phase 2 Status: Completed
Date: 2019-08-01
Different dosing of Tranexamic Acid in patients undergoing elective total hip or knee arthroplasty. A randomized, controlled, double-blinded clinical trial.
CTID: null
Phase: Phase 2 Status: Ongoing
Date: 2019-02-18
Study of thromboelastography during tranexamic acid treatment in preventing bleeding in patients with haematological malignancies presenting severe thrombocytopenia (TTRAP-bleeding)
CTID: null
Phase: Phase 2 Status: Completed
Date: 2019-02-12
PeriOperative ISchemic Evaluation-3 (POISE-3) Trial
CTID: null
Phase: Phase 3 Status: Ongoing, Completed
Date: 2018-12-11
Efficacy and safety of levocetirizine alone or in combination with tranexamic acid in the treatment of spontaneous chronic urticaria. Multicentric controlled randomized study in cross-over, double-blind.
CTID: null
Phase: Phase 3 Status: Ongoing
Date: 2018-12-04
TRANSFUSION OF RED BLOOD CELLS, TRANEXAMIC ACID AND FIBRINOGEN CONCENTRATE FOR SEVERE TRAUMA HEMORRHAGE AT PRE-HOSPITAL PHASE OF CARE. A PILOT TRIAL.
CTID: null
Phase: Phase 2 Status: Completed
Date: 2018-09-27
Tranexamic acid use to reduce de blood transfusion in femur fracture patients. Clinical randomized trial with placebo control
CTID: null
Phase: Phase 4 Status: Ongoing
Date: 2018-07-12
Tranexamic Acid to Prevent Operation in Chronic Subdural Hematoma
CTID: null
Phase: Phase 3 Status: Ongoing
Date: 2018-05-24
Reduction of bleeding during abdominal plastids with Exacyl®
CTID: null
Phase: Phase 4 Status: Completed
Date: 2018-05-14
Tranexamic Acid to reduce bleeding in patients treated with new oral anticoagulants undergoing dental extraction (EXTRACT-NOAC)
CTID: null
Phase: Phase 4 Status: Prematurely Ended
Date: 2018-01-03
TRAnexamic Acid for Preventing postpartum hemorrhage following a Cesarean Delivery :a multicenter randomised, double blind placebo controlled trial (TRAAP2)
CTID: null
Phase: Phase 3 Status: Completed
Date: 2017-11-23
Randomized, placebo-controlled, double-blind trial to evaluate the efficacy and safety of topical application of tranexamic acid for saving blood losses in patients subjected to prosthetic knee surgery.
CTID: null
Phase: Phase 3 Status: Completed
Date: 2017-11-13
A randomised controlled trial of topical intranasal tranexamic acid versus placebo to reduce the need for nasal packing in patients presenting to the Emergency Department with spontaneous epistaxis.
CTID: null
Phase: Phase 3 Status: Completed
Date: 2017-02-20
Randomized, double-blind, 3-arm trial to evaluate the impact of blood loss following administration of three tranexamic acid regimens in patients undergoing bone or soft tissue sarcomas.
CTID: null
Phase: Phase 3 Status: Ongoing
Date: 2017-02-09
TREATT: TRial to EvaluAte Tranexamic acid therapy in Thrombocytopenia
CTID: null
Phase: Phase 3 Status: GB - no longer in EU/EEA
Date: 2016-08-23
Human intestinal ischemia and reperfusion
CTID: null
Phase: Phase 4 Status: Ongoing
Date: 2016-06-06
Single centre randomised controlled trial to assess the effect of the addition of twenty-four hours of oral tranexamic acid post-operatively to a single intra-operative intravenous dose of tranexamic acid on calculated blood loss following primary hip and knee arthroplasty.
CTID: null
Phase: Phase 4 Status: Completed
Date: 2016-03-10
TIME OF ADMINISTRATION OF TRANEXAMIC ACID TO PREVENT BLEEDING IN TOTAL KNEE ARTHROPLASTY
CTID: null
Phase: Phase 4 Status: Ongoing
Date: 2016-03-10
Tranexamic acid to reduce blood loss in hemorrhagic caesarean delivery: a multicenter randomized double blind placebo
CTID: null
Phase: Phase 3 Status: Prematurely Ended
Date: 2016-02-02
Effects of Tranexamic Acid on on Intra- and Postoperative bleeding, Blood transfusion and Coagulation in Children Undergoing Craniosynostosis Surgery
CTID: null
Phase: Phase 4 Status: Completed
Date: 2015-08-05
Etude ESPER : Epargne Sanguine au cours de la pose d’une Prothèse de hanche totale grâce à l’Exacyl® chez le patient traité par Rivaroxaban
CTID: null
Phase: Phase 4 Status: Completed
Date: 2015-03-25
Tranexamic acid in major vascular surgery (Tranex-AAA)
CTID: null
Phase: Phase 4 Status: Completed
Date: 2015-01-05
The Effectiveness and Population Pharmacokinetics and Pharmacogenomics of a Reduced Dose of Tranexamic Acid for Craniosynostosis Surgery: A multicenter study. The TXA Study.
CTID: null
Phase: Phase 3 Status: Ongoing
Date: 2014-11-24
TRAnexamic Acid for Preventing postpartum hemorrhage
CTID: null
Phase: Phase 3 Status: Completed
Date: 2014-08-21
A ONE YEAR STUDY ON THE USE OF TRANEXAMIC ACID IN BENIGN PROSTATIC HYPERPLASIA SURGERY
CTID: null
Phase: Phase 4 Status: Ongoing
Date: 2014-05-07
Prevention of bleeding and edema in bi-maxillary orthognathic surgery; the effectiveness of tranexamic acid on intraoperative bleeding in orthognathic surgery
CTID: null
Phase: Phase 4 Status: Completed
Date: 2014-04-24
Topical application of tranexamic acid compared to the intravenous administration in total hip arthroplasty with the direct anterior approach. A prospective, randomized, clinical trial.
CTID: null
Phase: Phase 2 Status: Ongoing
Date: 2013-12-19
STOP-AUST: The Spot sign and Tranexamic acid On Preventing ICH growth – AUStralasia Trial
CTID: null
Phase: Phase 2 Status: Completed
Date: 2013-12-10
Evaluation of intra articular Tranexamic acid for reduction of total blood loss in total knee unilateral arthroplasty
CTID: null
Phase: Phase 4 Status: Completed
Date: 2013-10-30
Evaluation of postoperative administration of tranexamic acid on reducing blood loss after hip prothesis surgery.
CTID: null
Phase: Phase 4 Status: Completed
Date: 2013-08-08
The effect on blood loss with combined topical and intravenous tranexamic acid in cardiac surgery patients: a randomized double-blind placebo-controlled trial
CTID: null
Phase: Phase 4 Status: Ongoing
Date: 2013-04-24
Pilot study on efficacy of bilastine in preventing angioedema symptoms in patients with angioedema of unknown etiology (idiopathic angioedema, IAE)
CTID: null
Phase: Phase 2 Status: Prematurely Ended
Date: 2013-03-23
Tranexamic acid for the treatment of gastrointestinal haemorrhage: an international randomised, double blind placebo controlled trial
CTID: null
Phase: Phase 3 Status: Prematurely Ended, Completed
Date: 2013-02-22
Peroperative Tranexamic acid as prophylaxis of bleeding related to benign hysterectomy - a randomized, placebo-controlled trial
CTID: null
Phase: Phase 4 Status: Completed
Date: 2013-02-07
Tranexamic Acid for the treatment of significant traumatic brain injury: an international, randomised, double blind, placebo controlled trial.
CTID: null
Phase: Phase 3 Status: Completed
Date: 2012-12-03
Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage TICH-2
CTID: null
Phase: Phase 3 Status: Completed
Date: 2012-11-23
Efficacy of topical tranexamic acid versus intravenous administration to reduce blood transfussion rate in total knee arthroplasty surgery: phase III, unicentric, controlled,double blind, randomized non inferiority clinical trial.
CTID: null
Phase: Phase 3 Status: Completed
Date: 2012-11-08
Ultra-early tranexamic acid after subarachnoid hemorrhage.
CTID: null
Phase: Phase 3 Status: Completed
Date: 2012-09-06
Prevention of postoperative bleeding in bone tumors surgery: A multicenter, randomized, parallel controlled clinical trial evaluating the efficacy of topic fibrin glue, topic tranexamic acid and normal haemostasia in patients undergoing massive bone resection.
CTID: null
Phase: Phase 3 Status: Ongoing
Date: 2012-07-09
Prevention of postoperative bleeding: A multicenter, randomized, parallel, controlled clinical trial, evaluating the efficacy of tranexamic acid and fibrin glue in patients undergoing interventions for sub-capital femoral fracture.
CTID: null
Phase: Phase 3 Status: Ongoing
Date: 2012-07-09
A Phase II, double-blind, parallel group, dose-selection study to compare antifibrinolytic MDCO-2010 vs. placebo and tranexamic acid in reducing blood loss in patients undergoing primary cardiac surgery
CTID: null
Phase: Phase 2 Status: Prematurely Ended
Date: 2012-04-03
Prevención del sangrado postoperatorio en artroplastia total de rodilla: Ensayo clínico multicéntrico, aleatorizado, abierto, paralelo de tres brazos de tratamiento, que evalúa la eficacia del ácido tranexámico endovenoso y tópico versus hemostasia habitual
CTID: null
Phase: Phase 3 Status: Ongoing
Date: 2011-11-30
International, prospective, double-blind, 3-arm comparative, randomized, placebo controlled phase IV study on the effect of counseling and either tranexamic acid or
CTID: null
Phase: Phase 4 Status: Completed
Date: 2011-03-01
Tranexamic acid for the treatment of postpartum haemorrhage: An international randomised, double blind, placebo controlled trial
CTID: null
Phase: Phase 3 Status: Completed
Date: 2011-02-17
ACIDO TRANEXAMICO FRENTE A PLACEBO PARA LA REDUCCION DE LAS PERDIDAS SANGUINEAS EN LA CIRUGIA DE REEMPLAZO TOTAL DE CADERA: ENSAYO CLINICO ALEATORIZADO
CTID: null
Phase: Phase 3 Status: Ongoing
Date: 2010-11-12
A randomis
e.querySelector("font strong").innerText = 'View More'
} else if(up_display === 'none' || up_display === '') {
icon_angle_down.style.display = 'none';
